Linked Life Data

15621128

Source:http://linkedlifedata.com/resource/pubmed/id/15621128

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2004-12-28
pubmed:abstractText
Gingival hyperplasia is a well-known complication of cyclosporine therapy, affecting 21% to 35% of renal transplant patients. Metronidazole, clarithromycin, and azithromycin, all azalid antimicrobial agents derived from the macrolide antibiotic erythromycin, have been used for treatment. Marked improvements in gingival hyperplasia have been recorded in particular with azithromycin. The aim of the present study was to investigate histopathological features of cyclosporine-induced gingival hyperplasia and to evaluate the quantitative efficacy of short-term azithromycin therapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0041-1345
pubmed:author
pubmed:issnType
Print
pubmed:volume
36
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2699-702
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Effects of azithromycin on cyclosporine-induced gingival hyperplasia in renal transplant patients.
pubmed:affiliation
Department of Nephrology, Erciyes University, Kayseri, Turkey. tokgozb@erciyes.edu.tr.
pubmed:publicationType
Journal Article, Clinical Trial